Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis

Lupus

Volumn 21, Issue 4, 2012, Pages 412-420

  Szmyrka Kaczmarek, M ^a   Pokryszko Dragan, A ^a   Pawlik, B ^a   Gruszka, E ^a   Korman, L ^a   Podemski, R ^a   Wiland, P ^a   Szechinski, J ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

anti beta2 glycoprotein I antibodies; anticardiolipin antibodies; antinuclear antibodies; connective tissue diseases; multiple sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; CELL NUCLEUS ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DISABILITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OPTIC NEURITIS; PREVALENCE; PRIORITY JOURNAL; SYMPTOM;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, ANTIPHOSPHOLIPID; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CONNECTIVE TISSUE DISEASES; DISABILITY EVALUATION; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; POLAND; PROGNOSIS; SEROLOGIC TESTS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84858669307     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311427550     Document Type: Article

References (31)

1. Fraussen J, Vrolix K, Martinez-Martinez P, et al. B cell characterization and reactivity analysis in multiple sclerosis. Autoimmun Rev. 2009 ; 8: 654-658
2. Franciotta D, Salvetti M, Lolli F, Serafini B, Aloisi F. B cells and multiple sclerosis. Lancet Neurol. 2008 ; 7: 852-858
3. Archelos JJ, Storch MK, Hartung HP. The role of B cells and autoantibodies in MS. Ann Neurol. 2000 ; 47: 694-706
4. Hauser SL, Waubant E, Arnold DL, et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med. 2008 ; 358: 676-688 (Pubitemid 351240747)
5. Spadaro M, Amendolea MA, Mazzucconi MG, et al. Autoimmunity in multiple sclerosis: a study of wide spectrum of autoantibodies. Mult Scler. 1999 ; 5: 121-125 (Pubitemid 29186830)
6. Roussel V, Yi F, Jauberteau O, et al. Prevalence and clinical significance of antiphospholipid antibodies in multiple sclerosis: a study of 89 patients. J Autoimmun. 2000 ; 14: 259-265
7. Tourbah A, Clapin A, Gout O, et al. Systemic autoimmune features and multiple sclerosis. A 5-year follow up. Arch Neurol. 1998 ; 55: 517-521 (Pubitemid 28182698)
8. Gaarg N, Zivadinov R, Ramanathan M, et al. Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients. J Neuroimmunol. 2007 ; 187: 159-165 (Pubitemid 47001541)
9. Ijdo JW, Conti-Kelly AM, Greco P, et al. Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS?. Lupus. 1999 ; 8: 109-115 (Pubitemid 29103596)
10. Fukazawa T, Moriwaka F, Mukai M, Hamada T, Koike T, Tashiro K. Anticardiolipin antibodies in Japanese patients with multiple sclerosis. Acta Neurol Scand. 1993 ; 88: 184-189 (Pubitemid 23288652)
11. Karussis D, Leker RR, Ashkenazi A, Abramsky O. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity?. Ann Neurol. 1998 ; 44: 629-634 (Pubitemid 28477850)
12. Hughes GRV. The antiphospholipid syndrome and 'multiple sclerosis'. Lupus. 1999 ; 8: 89-89
13. Ferreira S, D'Cruz D, Hughes GRV. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?. Rheumatology (Oxford). 2005 ; 44: 434-442 (Pubitemid 41511130)
14. Chapman J, Rand JH, Brey RL, et al. Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies. Lupus. 2003 ; 12: 514-517 (Pubitemid 36890142)
15. Cuadrado MJ, Khamashta MA, Ballesteros A, et al. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Lupus. 2000 ; 79: 57-68 (Pubitemid 30077737)
16. McDonald WJ, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 ; 50: 121-127
17. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 ; 33: 1444-1452 (Pubitemid 14237132)
18. Roxburgh RHSR, Seaman SR, Masterman T, et al. Multiple Sclerosis Severity Score. Using disability and disease duration to rate disease severity. Neurology. 2005 ; 64: 1144-1151
19. Schwartz M, Kipnis J. Multiple sclerosis as a by-product of the failure to sustain protective autoimmunity: a paradigm shift. Neuroscientist. 2002 ; 8: 405-413
20. Luchinetti CF, Reingold SC, Eden G, et al. Multiple sclerosis-lessons from neuropathology. Semin Neurol. 1998 ; 18: 337-349
21. Luchinetti CF, Parisi J, Bruck W. The pathology of multiple sclerosis. Neurol Clin. 2005 ; 23: 77-105 (Pubitemid 40126916)
22. Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol. 2004 ; 55: 458-468 (Pubitemid 38391962)
23. Barnett MH, Sutton I. The pathology of multiple sclerosis: a paradigm shift. Curr Opin Neurol. 2006 ; 19: 242-247 (Pubitemid 43804677)
24. Bidot CJ, Horstman LL, Jy W, et al. Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study. BMC Neurol. 2007 ; 18: 36-36
25. Sastre-Garriga JJ, Reverter JC, Font J, Tintoré M, Espinosa G, Montalban X. Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis. Ann Neurol. 2001 ; 49: 408-411 (Pubitemid 32202798)
26. Heinzlef O, Weill B, Johanet C, et al. Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial and biological characteristics. J Neurol Neurosurg Psychiatry. 2002 ; 72: 647-649 (Pubitemid 34462823)
27. Harada T, Ohashi T, Fukazawa T, et al. Visual function in patients with optic neuritis associated with acute transverse myelopathy in multiple sclerosis. Jpn J Ophthalmol. 1993 ; 39: 290-294
28. Sugiyama Y, Yamamoto Y. Characterization of serum anti-phospholipid antibodies in patients with multiple sclerosis. Tohoku J Exp Med. 1996 ; 178: 203-215 (Pubitemid 126512209)
29. Cordoliani MA, Michon-Pasturel U, Arvieux RK, et al. [Multiple sclerosis and antiphospholipid antibodies: study of 62 consecutive patients]. Rev Med Interne. 1998 ; 19: 635-639 (Pubitemid 28429636)
30. Colosimo C, Pozilli C, Frontoni M, et al. No increase of serum autoantibodies during therapy with recombinant human interferon-b-1a in relapsing remitting multiple sclerosis. Acta Neurol Scand. 1997 ; 96: 372-374 (Pubitemid 28011094)
31. Ciccarelli O, Bagnato F, Mainero C, et al. Antinuclear antibodies and response to IFN-β therapy in relapsing-remitting multiple sclerosis. Mult Scler. 2000 ; 6: 137-139 (Pubitemid 30392109)